Aging/Research reports/2026-10-09
TIMP2: A memory benefit—but through what mechanism, and for how long?
Project status: 🔵 Level 2 · AG-C03 / AG-T01. Our synthesis requires testing. Scientific evidence: preclinical intervention finding, only partly appraised methodologically today. No confirmed human rejuvenation or experimental reproduction by this project.
What becomes better grounded today
AG-R05 is not a new publication. Indexed original passages extend its previous abstract entry: recombinant TIMP2 was compared with vehicle in 20-month-old WT mice, 15 animals per group, with eight doses every other day. The authors report direct Barnes-maze and contextual-memory benefits. The slice-physiology legend specifies ten slices from five mice per group. Cord-plasma depletion belongs to a separate experiment. Original text, Fig. 4
What we do not quantify: Exact test assignments, effect size, confidence interval and treatment-to-test calendar were not verified. No plots were digitised or raw data reanalysed. Treatment duration does not establish persistent benefit after withdrawal. Discrepant route labels in Fig. 4e/f and Extended Data 8c remain unresolved. Original legends
Three questions require different evidence
The following decision matrix is our methodological interpretation, not another study result.
| Question | Today's decision |
|---|---|
| Is there a direct functional contrast? | Reported in AG-R05; numerical precision remains open. Earlier criticism of separate AG-R08 tests against chance must not be generalised to this experiment. |
| Does selective cargo degradation mediate the benefit? | Not identified. Direct neuronal or matrix effects remain countermodels; a functional contrast alone cannot distinguish these pathways. |
| Does benefit persist after treatment ends? | Not established here. Learning/test duration and post-withdrawal follow-up address different questions. |
An evidence chain, not a tally of positive findings
Our inference: This functional anchor is more specific than comparing individual groups with chance. It does not close the gap between TIMP2, selective degradation, synapse preservation and lasting function. Mouse treatment and measurements of multiple slices from the same animal operate at different levels; extra slices do not increase the number of independently treated animals. Pooling unlike studies into one effect estimate would be unjustified without suitable data.
Established knowledge within the project: The named findings are reported in scientific literature; this does not independently confirm every claimed effect. Promising indication: the reported direct functional comparison. Experimental model result: the authors' mouse finding, not human efficacy. Hypothesis: AG-T01 links selective degradation to preserved function; support remains low and its status remains Level 2.
Next executable countercheck
Compare authors, institutions and material/data references across AG-R05, AG-R08 and AG-R01. Different DOIs or assays do not establish independent reproduction. Only with newly accessible complete original methods/source data should the bounded Fig. 4a–c audit follow: direct statistics, mouse-level values, exclusions, last dose and testing time. If function remains explainable without the proposed degradation pathway, AG-T01 must be constrained accordingly. An external mediation experiment would be one possible validation route; none was performed.
Sources, access and cumulative update
- Castellano JM et al., Human umbilical cord plasma proteins revitalize hippocampal function in aged mice, Nature. First published 19 April 2017; issue date 27 April 2017. DOI 10.1038/nature22067. Retrieved 9 October 2026. Evidence: preclinical intervention; limited methods audit, no comprehensive safety assessment.
- Direct access was limited; the audit used indexed original text/legends, not a complete figure/supplement appraisal. Targeted correction/retraction search found no attributable new notice; completeness is not guaranteed.
- Source delta 0: 28 distinct studies remain registered. Axolotl gaps and the parked AG-D06 supplement question remain open. No new data or experiments today; no status increase.
- Evidence chain · Approaches registry · Documented search · Professor research colloquium. Existing methods modules cover this refinement; no duplicate wishlist package.
Continue exploring
